Capital World Investors Increases Stock Holdings in Ryan Specialty Holdings Inc. $RYAN

Capital World Investors lifted its position in Ryan Specialty Holdings Inc. (NYSE:RYANFree Report) by 0.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,640,638 shares of the company’s stock after purchasing an additional 17,082 shares during the quarter. Capital World Investors owned about 2.52% of Ryan Specialty worth $342,856,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Beck Mack & Oliver LLC purchased a new stake in shares of Ryan Specialty in the third quarter valued at about $2,818,000. Westview Management dba Westview Investment Advisors purchased a new stake in shares of Ryan Specialty in the fourth quarter valued at about $2,082,000. Geneva Capital Management LLC grew its holdings in shares of Ryan Specialty by 11.2% in the third quarter. Geneva Capital Management LLC now owns 535,742 shares of the company’s stock valued at $30,194,000 after purchasing an additional 53,810 shares during the period. SG Americas Securities LLC purchased a new stake in shares of Ryan Specialty in the fourth quarter valued at about $20,776,000. Finally, JPMorgan Chase & Co. grew its holdings in shares of Ryan Specialty by 149.7% in the third quarter. JPMorgan Chase & Co. now owns 421,330 shares of the company’s stock valued at $23,746,000 after purchasing an additional 252,582 shares during the period. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the stock. UBS Group set a $39.00 price objective on shares of Ryan Specialty in a report on Thursday, May 21st. Morgan Stanley decreased their target price on shares of Ryan Specialty from $45.00 to $39.00 and set an “overweight” rating on the stock in a research report on Thursday, May 21st. Piper Sandler decreased their target price on shares of Ryan Specialty from $43.00 to $35.00 and set a “neutral” rating on the stock in a research report on Friday, May 1st. Zacks Research cut shares of Ryan Specialty from a “hold” rating to a “strong sell” rating in a research report on Tuesday, February 24th. Finally, BMO Capital Markets cut shares of Ryan Specialty from an “outperform” rating to a “market perform” rating and decreased their target price for the company from $66.00 to $43.00 in a research report on Wednesday, February 25th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have given a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $46.35.

Get Our Latest Analysis on Ryan Specialty

Insider Activity

In other Ryan Specialty news, Chairman Patrick G. Ryan purchased 120,000 shares of Ryan Specialty stock in a transaction dated Friday, June 5th. The shares were acquired at an average price of $32.50 per share, with a total value of $3,900,000.00. Following the completion of the transaction, the chairman owned 13,817,859 shares of the company’s stock, valued at $449,080,417.50. This trade represents a 0.88% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Mark Stephen Katz purchased 3,215 shares of Ryan Specialty stock in a transaction dated Wednesday, June 3rd. The shares were acquired at an average cost of $31.07 per share, for a total transaction of $99,890.05. Following the transaction, the executive vice president directly owned 4,332 shares of the company’s stock, valued at approximately $134,595.24. This represents a 287.82% increase in their position. The disclosure for this purchase is available in the SEC filing. 52.03% of the stock is currently owned by corporate insiders.

Ryan Specialty Trading Down 2.8%

NYSE RYAN opened at $31.66 on Tuesday. The stock has a market capitalization of $8.35 billion, a P/E ratio of 41.11, a PEG ratio of 0.78 and a beta of 0.64. Ryan Specialty Holdings Inc. has a 12 month low of $29.28 and a 12 month high of $69.49. The company has a debt-to-equity ratio of 2.90, a current ratio of 1.02 and a quick ratio of 1.02. The firm’s 50-day moving average is $33.49 and its two-hundred day moving average is $42.35.

Ryan Specialty (NYSE:RYANGet Free Report) last issued its quarterly earnings results on Thursday, April 30th. The company reported $0.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.04. The business had revenue of $795.23 million for the quarter, compared to analysts’ expectations of $781.44 million. Ryan Specialty had a net margin of 8.21% and a return on equity of 41.33%. The business’s quarterly revenue was up 15.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.39 earnings per share. On average, sell-side analysts anticipate that Ryan Specialty Holdings Inc. will post 2.05 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, May 26th. Stockholders of record on Tuesday, May 12th were given a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend was Tuesday, May 12th. Ryan Specialty’s dividend payout ratio is currently 67.53%.

Ryan Specialty announced that its Board of Directors has authorized a stock buyback plan on Tuesday, May 26th that permits the company to repurchase $300.00 million in outstanding shares. This repurchase authorization permits the company to reacquire up to 3.5% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.

About Ryan Specialty

(Free Report)

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.

Further Reading

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYANFree Report).

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.